It's a shot in the arm for Cambridge, Massachusetts-based Moderna as it faces an evolving regulatory environment for vaccines ...

Moderna said on Monday its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose seasonal flu shot in adults aged 50 years and older in a late-stage ...

The shot’s efficacy was 27% higher than a licensed influenza vaccine in adults 50 years and older, the company said in a statement Monday. The trial enrolled more than 40,000 adults across 11 ...

The long and winding journey of Moderna’s mRNA flu vaccine toward regulators has come one step closer with a phase 3 win over an approved competitor shot. Moderna said its own vaccine, dubbed ...

Moderna ’s mRNA vaccine for seasonal influenza, mRNA-1010, outperformed a currently available shot in older adults in a Phase III trial, paving the way not only toward a regulatory submission but also ...

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...

Holidaymakers have been alerted to a disruption in the supply of a crucial vaccine, which is expected to be 'unavailable' for the next 2-3 weeks. Sanofi has informed NaTHNaC that there will be a ...

Secretary Robert F. Kennedy Jr. has opened a new chapter of federal vaccine policy that invites questions on issues long ...

Nagpur: \"HPV vaccines are not only for girls. boys from 9 to 26 years of age should also take them. HPV isn't just about ...

Kennedy Jr.’s former group against the owner of Facebook. Children’s Health Defense, an anti-vaccine group founded by Kennedy before he joined President Donald Trump’s administration, argues its First ...

Last summer, the Vanderburgh County Health Department commissioned a survey meant to dig up the roots of vaccine hesitancy among parents and find ways to respond. Among the findings: 18% of parents ...